Does baxdrostat reduce blood pressure in patients with treatment-resistant hypertension?
Baxdrostat provides dose-related reductions in blood pressure for patients with treatment-resistant hypertension.
Patients with treatment-resistant hypertension who received baxdrostat had dose-related reductions in blood pressure. (Funded by CinCor Pharma; BrigHTN ClinicalTrials.gov number, NCT04519658.).
Freeman et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: